focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (13.043%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 24.50
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Elixirr meets guidance, in strong start to 2023

Mon, 27th Feb 2023 10:37

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Elixirr International PLC, up 20% at 503.0 pence, 12-month range 412p-780p. The consultancy firm says 2022 was a strong year, with all metrics to be "in line or above" market expectations. Revenue is expected to rise 40% to GBP70.7 million, within previous guidance, and adjusted earnings before interest, tax, depreciation and amortisation is expected at GBP20.4 million - which is in line with Elixirr's guidance of exceeding GBP20 million. Says 2023 has started "strongly" with an acceleration of organic growth in the first quarter, and January seeing record monthly revenue.

----------

Directa Plus PLC, up 10% at 87p, 12-month range 76p-87p. The graphene nanoplatelet products producer and supplier says revenue in 2022 is now expected at not less than EUR10.8 million, which is up from EUR10.0 million communicated back in December's trading update. This represents a 25% increase year-on-year. Says momentum has continued into 2023, with trading meeting market expectations, which Directa cites as revenue of EUR13.5 million for the year.

----------

AIM - LOSERS

----------

Hercules Site Services PLC, down 38% at 44.99p, 12-month range 40p-73p. The labour supply company for the UK infrastructure sector raises GBP1.7 million in a placing of 3.8 million shares at issue price of 45p - which represents a 24% discount to Friday's closing price of 59p. "With a strong 2023 pipeline in place, these funds will support further organic growth in our Labour Supply division, which represented over 67% of our revenue in 2022," says Chief Executive Brusk Korkmaz.

----------

Oncimmune Holdings PLC, down 23% at 42p, 12-month range 36.69p-146.0p. The immuno-diagnostics developer says, in the 15 months to August 31, revenue was GBP3.8 million, little changed from GBP3.7 million in the year to May 31. Pretax loss widens to GBP11.6 million from GBP6.1 million across the same time frame. However, says revenue in the first six months of financial 2023 are expected to exceed GBP3.8 million, and it expects to be operating cashflow positive during the year.

----------

Forward Partners Group PLC, down 6.5% at 36p, 12-month range 35p-98.4p. The early-stage technology-focused investor says the fair value of its portfolio fell 40% to no less than GBP79.0 million at December 31, from GBP117.1 million a year before. Net asset value per share is expected to plunge to 71.0p from 104p a year before. The investment firm blamed valuation headwinds, "due to public market and macroeconomic pressures". "Despite the pressure on valuations many of them still grew rapidly," says Chief Executive Nic Brisbourne.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Sep 2018 11:43

Oncimmune Appoints Adam Hill As New Boss, Founder Becomes Vice Chair

LONDON (Alliance News) - Oncimmune Holdings PLC said Monday it appointed Adam Hill as its new boss as current Chief Executive Officer Geoffrey Hamilton-Fairley prepares to move to vice-chairman -

Read more
27 Mar 2018 13:34

Oncimmune Gets Final GBP3 Million Genostics Investment After Deal (ALLISS)

LONDON (Alliance News) - Oncimmune Holdings PLC said Tuesday it has received the final GBP3.0 million tranche of a GBP10.0 million investment Co

Read more
7 Nov 2016 15:17

Revenue shrinks and costs rise at Oncimmune

(ShareCast News) - Early cancer detection company Oncimmune Holdings announced its full year results for the year to 31 May on Monday, including £12.2m raised by the issue of equity in the year. The firm also said £4.2m of convertible loan notes were converted. Revenues for the year were down signi

Read more
22 Sep 2016 09:01

Oncimmune Notes Asia Focus With Chief Commercial Officer Appointment

Read more
17 Aug 2016 07:23

Oncimmune Makes Acting CFO Millet Permanent Finance Chief

Read more
15 Jul 2016 16:17

Oncimmune secures CE mark for EarlyCDT-Lung

(ShareCast News) - Early cancer detection technology company Oncimmune Holdings announced on Friday that it has obtained the CE mark for the reagents used in its EarlyCDT-Lung product - an autoantibody blood test that can detect cancer up to four years earlier than other methods. The AIM-traded firm

Read more
15 Jul 2016 07:55

Oncimmune Secures European CE Mark For Product EarlyCDT-Lung

Read more
4 Jul 2016 07:26

Oncimmune Signs Research Agreements To Further Validate EarlyCDT Tests

Read more
6 Jun 2016 16:44

Oncimmunce Holdings CFO Robert Page dies

(ShareCast News) - Robert Page, director and CFO of Oncimmune Holdings, has died unexpectedly from natural causes. Oncimmune Holdings, an early cancer detection and technology company, said Page died on Friday morning. Page became CFO in 2005 after holding a series of finance roles at telecommunica

Read more
6 Jun 2016 13:21

Oncimmune Holdings Says Chief Financial Officer Robert Page Has Died

Read more
25 May 2016 07:58

Oncimmune Signs Three New Distribution Deals In US

Read more
18 May 2016 08:46

Oncimmune Starts Trading On AIM As Motorpoint Shares Stay Firm (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.